샘플 요청 목록

 카트 문의
시장보고서
상품코드
1792828

세계의 월경전증후군 및 월경 건강보조제 시장

Premenstrual Syndrome and Menstrual Health Supplements
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 463 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

월경전증후군 및 월경 건강보조제 세계 시장은 2030년까지 246억 달러에 달할 전망

2024년에 200억 달러로 추정되는 월경전증후군 및 월경 건강보조제 세계 시장은 2024년부터 2030년까지 CAGR 3.6%로 성장하여 2030년에는 246억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 복합 영양 보충제는 CAGR 2.9%를 기록하며 분석 기간 종료시에는 152억 달러에 달할 것으로 예측됩니다. 단일 영양 보충제 부문의 성장률은 분석 기간 동안 CAGR 4.6%로 추정됩니다.

미국 시장은 54억 달러로 추정, 중국은 CAGR 6.5%로 성장 예측

미국의 월경전증후군 및 월경 건강보조제 시장은 2024년에는 54억 달러에 달할 것으로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 49억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 6.5%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.5%와 2.7%로 예측됩니다. 유럽에서는 독일이 CAGR 2.0%로 성장할 것으로 예측됩니다.

세계의 월경전증후군 및 월경 건강보조제 시장 - 주요 동향과 촉진요인 정리

건강보조식품의 혁신은 여성의 월경 건강 관리를 어떻게 재구성하고 있는가?

월경전증후군(PMS) 및 월경 건강보조제 시장은 호르몬 균형, 염증 조절, 정서적 안녕을 목표로 하는 특수 영양 보충제의 등장으로 인해 큰 변화를 겪고 있습니다. 최근에는 체스트베리 추출물(비텍스 아그누스 카스투스), 마그네슘, 비타민 B6, 칼슘, 달맞이꽃 오일, 오메가 3 지방산 등 기분 저하, 경련, 복부 팽만감, 피로 등의 증상을 완화시키는 것으로 알려진 임상적으로 연구된 성분을 중심으로 만들어지는 경우가 많아지고 있습니다. 이러한 생리활성 화합물은 신경전달물질 조절, 프로스타글란딘 조절, 내분비계 균형을 지원하여 단순히 증상을 숨기는 것이 아니라 PMS의 근본적인 메커니즘에 직접적으로 작용합니다.

최근 기술 혁신을 통해 적응제(아슈와간다, 로디올라 로제아 등), 식물성 에스트로겐(콩 이소플라본 등), 항염증 허브(강황, 생강 등)를 조합한 시너지 효과의 블렌딩을 통해 생리 주기의 다양한 단계에 맞는 총체적인 종합적인 보충제 솔루션을 만들어 내고 있습니다. 타임 릴리스 캡슐, 설하 스프레이, 기능성 구미는 생체 이용률과 사용자 순응도를 향상시켜 일반적인 전달 형태로 자리 잡고 있습니다. 또한, AI 기반 보충제 개인화 플랫폼이 등장하여 호르몬 프로파일링, 라이프스타일, 식습관 등을 기반으로 알고리즘이 생성한 추천 제품을 제공하고 있습니다. 이러한 발전으로 인해 보충제는 단순히 증상을 관리하는 것뿐만 아니라 여성 생식 건강이라는 큰 관점에서 장기적인 건강을 최적화하는 것으로 자리매김하고 있습니다.

건강기능식품은 기존의 시중에서 판매되는 완화제품을 넘어 어디까지 진출할 수 있을까?

PMS와 월경 건강을 위한 보충제는 약국이나 소매 체인의 틀을 넘어 다양한 새로운 영역에서 인기를 끌고 있습니다. 디지털 헬스 분야에서는 생리 추적 앱을 제공하는 펨테크 플랫폼이 보충제 정기 구매와 개인화된 주기에 대한 인사이트를 통합한 생리 추적 앱을 제공하고 있습니다. DTC(Direct-to-Consumer) 브랜드는 월경 건강 키트에 보충제, 허브차, 프로바이오틱스를 결합한 월경 건강 키트를 정기 구매 기반 웰니스 에코시스템의 일부로 패키징하고 있습니다. 이 제품들은 편의성, 프라이버시, 투명성을 추구하는 소비자, 특히 천연 대체품과 첨단 기술을 활용한 건강 솔루션에 매력을 느끼는 젊은 층을 타겟으로 하고 있습니다.

직장과 대학도 유통 거점으로 부상하고 있으며, 기업 웰니스 프로그램과 학생 건강 이니셔티브는 더 광범위한 월경 평등 캠페인의 일환으로 보충제에 대한 접근성을 제공하고 있습니다. 이와 함께 불임 클리닉과 부인과 센터에서는 불규칙한 생리주기, 다낭성난소증후군(PCOS), 황체기 부전을 경험하는 환자를 위한 통합적 치료 계획에 보충제를 도입하고 있습니다. 스포츠 및 활동적인 라이프스타일 분야에서 운동선수와 피트니스에 열성적인 여성들은 경기력의 안정성을 유지하기 위해 주기 조절 보충제를 사용하고 있습니다. 이러한 기관, 디지털, 라이프스타일 중심의 채널로의 확장은 보충제의 인지도를 높이고, 더 넓은 예방 건강의 틀에 보충제를 통합하고 있습니다.

소비자의 취향과 건강 인식의 변화가 제형과 브랜딩에 어떤 영향을 미치고 있는가?

현대 소비자, 특히 밀레니얼 세대와 Z세대는 클린 라벨, 비건, 비건, 알레르겐 프리, 윤리적으로 조달된 원료를 요구하며 생리 및 보충제 사용에 대한 기대치를 재정의하고 있습니다. 보충제 제조업체들은 이러한 기호에 부응하기 위해 유전자 변형이 없는 식물, 무설탕, 무플라스틱 포장, 제 3의 기관에 의한 테스트 등을 점점 더 강조하고 있습니다. 임상적 검증과 디지털 추적성을 바탕으로 한 라벨 표시의 투명성은 시장에서 성공하기 위한 필수 조건이 되고 있습니다. 인기 있는 포지셔닝 전략은 '호르몬 없는 구제', '근본적인 원인에 대한 지원', '사이클 싱크'에 초점을 맞추고, 치료에서 바디 리터러시와 임파워먼트로 이야기를 전환하고 있습니다.

소셜 미디어와 인플루언서 마케팅은 인지도를 형성하고 제품 발견을 촉진하는 데 중요한 역할을 하고 있습니다. 월경 과학, 신체 긍정성, 전인적 웰빙을 강조하는 교육 캠페인은 월경의 문화적 비물질화에 기여하고 있으며, 이를 통해 월경 지원 의식에 대한 수요를 촉진하고 있습니다. 또한, 트랜스젠더와 비이성애자, 비이성애자 월경인들을 위한 종합적인 브랜딩의 등장은 월경 건강보조식품의 이용자를 확대하고 있습니다. 다양한 세계 시장에 침투하기 위해 다국어 표시, 문화적 조정, 지역별 제품 처방이 사용되고 있습니다. 과학적 신뢰성, 윤리적 제조, 종합적인 커뮤니케이션의 융합은 월경 건강보조식품의 처방, 판매 및 소비의 방식을 재정의하고 있습니다.

월경 건강보조제 시장의 세계 성장을 이끄는 힘은 무엇일까?

세계 PMS 및 월경 건강보조제 시장의 성장은 여성 건강 문제에 대한 인식 증가, 생식 건강 정보에 대한 접근성 증가, 비약물적 개입에 대한 수요 증가에 힘입어 성장하고 있습니다. PMS는 전 세계적으로 월경하는 여성의 70% 이상에게 영향을 미치며, 그 증상은 가벼운 불편함에서 심각한 기분 장애 및 통증 장애에 이르기까지 다양하기 때문에 여성들은 기존의 진통제 및 호르몬 치료 대신 보다 안전하고 자연적인 대안을 적극적으로 찾고 있습니다. 이러한 수요는 특히 도시 지역과 건강관리에 적극적이고, 교육을 받고, 디지털로 연결된 사람들 사이에서 강합니다.

월경 위생 교육 및 월경 위생 관리(MHM)를 지원하는 정부 및 비정부 차원의 노력은 간접적으로 영양 불균형과 호르몬 건강에 대한 인식을 높이고 있습니다. 이와 병행하여, E-Commerce 플랫폼과 건강에 초점을 맞춘 마켓플레이스는 틈새시장과 프리미엄 보충제 브랜드에 대한 세계 접근을 가능하게 하고 있습니다. 월경 건강, 장 건강, 마음 건강, 호르몬 조화 등 보다 광범위한 웰빙 트렌드와의 교차점은 보다 광범위한 소비자 니즈를 충족시키기 위한 범 카테고리별 제품 혁신을 촉진하고 있습니다.

펨테크와 여성 중심의 건강 벤처에 대한 투자 의욕은 보충제 기업의 연구 개발 및 확장 능력을 촉진하고 더 빠른 제품 개발 및 세계 확장을 가능하게 합니다. 건강기능식품 브랜드와 헬스케어 전문가와의 전략적 파트너십을 통해 의료 수용성과 소비자 신뢰를 높이고 있습니다. 라이프스타일 웰빙 식단에의 통합, 건강보조식품에 대한 규제 당국의 지원 증가, 월경의 문화적 정상화 추세에 따라 PMS 및 월경 건강보조식품 시장은 향후 몇 년 동안 선진국과 신흥 지역 모두에서 두 자릿수 성장을 지속할 것으로 예상됩니다.

부문

제품 유형(복합 영양 보충제, 단일 영양 보충제), 적응증(갱년기장애 적응증, PMS 적응증), 형태(캡슐/정제 형태, 분말 형태, 소프트젤 형태, 기타 형태), 최종사용자(약국/드럭스토어 최종사용자, 온라인 유통 최종사용자, 직접 유통 최종사용자, 기타 최종사용자)

조사 대상 기업 사례

  • Amway
  • Bayer AG
  • Bonafide Health, LLC
  • Eu Natural
  • FLO Living
  • Garden of Life(Nestle Health Science)
  • GNC Holdings, LLC
  • Health & Her
  • Himalaya Wellness Company
  • HUM Nutrition Inc.
  • i-Health, Inc.(DSM-Firmenich)
  • Kora Organics
  • MaryRuth Organics
  • MegaFood(FoodState Inc.)
  • Nature's Bounty Co.
  • New Chapter, Inc.
  • Nutrafol
  • Olly PBC
  • Pink Stork
  • Sakara Life

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.27

Global Premenstrual Syndrome and Menstrual Health Supplements Market to Reach US$24.6 Billion by 2030

The global market for Premenstrual Syndrome and Menstrual Health Supplements estimated at US$20.0 Billion in the year 2024, is expected to reach US$24.6 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Combined Nutritional Supplements, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$15.2 Billion by the end of the analysis period. Growth in the Single Nutritional Supplements segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.4 Billion While China is Forecast to Grow at 6.5% CAGR

The Premenstrual Syndrome and Menstrual Health Supplements market in the U.S. is estimated at US$5.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Premenstrual Syndrome and Menstrual Health Supplements Market - Key Trends & Drivers Summarized

How Are Nutraceutical Innovations Reshaping Menstrual Health Management for Women?

The premenstrual syndrome (PMS) and menstrual health supplements market is undergoing a significant shift, propelled by the rise of specialized nutraceuticals targeting hormonal balance, inflammation control, and emotional well-being. Modern formulations are increasingly built around clinically studied ingredients such as chasteberry extract (Vitex agnus-castus), magnesium, vitamin B6, calcium, evening primrose oil, and omega-3 fatty acids-known to alleviate symptoms such as mood swings, cramps, bloating, and fatigue. These bioactive compounds support neurotransmitter regulation, prostaglandin modulation, and endocrine system balance, directly addressing underlying mechanisms of PMS rather than merely masking symptoms.

Recent innovations involve synergistic blends combining adaptogens (e.g., ashwagandha, Rhodiola rosea), phytoestrogens (e.g., soy isoflavones), and anti-inflammatory herbs (e.g., turmeric, ginger) to create holistic supplement solutions tailored for different phases of the menstrual cycle. Time-release capsules, sublingual sprays, and functional gummies are becoming popular delivery formats, enhancing bioavailability and user compliance. Additionally, AI-enabled supplement personalization platforms are emerging, offering algorithm-generated recommendations based on hormonal profiling, lifestyle, and diet. These advances are positioning supplements not just as symptom managers but as long-term health optimizers within the larger landscape of female reproductive wellness.

Where Are Supplements Gaining Ground Beyond Traditional Over-the-Counter Relief Products?

Supplements for PMS and menstrual health are gaining traction across a variety of new domains beyond pharmacies and retail chains. In the digital health space, femtech platforms offering menstrual tracking apps are integrating supplement subscriptions with personalized cycle insights. Direct-to-consumer (DTC) brands are packaging menstrual health kits that combine supplements, herbal teas, and probiotics as part of subscription-based wellness ecosystems. These offerings target consumers seeking convenience, privacy, and transparency-particularly younger demographics drawn to natural alternatives and tech-enabled health solutions.

Workplaces and universities are also emerging as distribution points, where corporate wellness programs and student health initiatives provide supplement access as part of broader menstrual equity campaigns. In parallel, fertility clinics and gynecology centers are incorporating supplements into integrative treatment plans for patients experiencing irregular cycles, polycystic ovarian syndrome (PCOS), and luteal phase defects. In sports and active lifestyles segments, athletes and fitness-focused women are turning to cycle-regulating supplements to maintain performance consistency. This expansion into institutional, digital, and lifestyle-driven channels is increasing supplement visibility and embedding it within a wider preventive health framework.

How Are Changing Consumer Preferences and Health Awareness Impacting Formulation and Branding?

Modern consumers-especially millennials and Gen Z-are redefining expectations around menstruation and supplement use by demanding clean-label, vegan, allergen-free, and ethically sourced ingredients. Supplement manufacturers are increasingly emphasizing non-GMO botanicals, zero added sugar, plastic-free packaging, and third-party testing to appeal to these preferences. Transparency in labeling, backed by clinical validation and digital traceability, is becoming a prerequisite for market success. Popular positioning strategies focus on "hormone-free relief," "root-cause support," and “cycle syncing,” shifting the narrative from disorder treatment to body literacy and empowerment.

Social media and influencer marketing are playing a critical role in shaping perceptions and driving product discovery. Educational campaigns emphasizing menstrual science, body positivity, and holistic wellness are contributing to a cultural destigmatization of menstruation-thereby fostering demand for monthly support rituals. Furthermore, the rise of inclusive branding that addresses transgender and non-binary menstruators is expanding the audience for menstrual health supplements. Multilingual labeling, cultural tailoring, and region-specific product formulations are being used to penetrate diverse global markets. This fusion of scientific credibility, ethical manufacturing, and inclusive communication is redefining the way menstrual health supplements are formulated, marketed, and consumed.

What Forces Are Driving the Global Growth of the Menstrual Health Supplements Market?

The growth in the global PMS and menstrual health supplements market is driven by rising awareness of women’s health issues, increased access to reproductive wellness information, and growing demand for non-pharmaceutical interventions. As the prevalence of PMS affects over 70% of menstruating individuals globally-with symptoms ranging from mild discomfort to severe mood and pain disorders-women are actively seeking safer, natural alternatives to conventional analgesics and hormonal treatments. This demand is particularly strong in urban areas and among educated, digitally connected populations who are proactive in health management.

Government and non-government initiatives supporting menstrual health education and menstrual hygiene management (MHM) are indirectly boosting awareness of nutritional gaps and hormonal health. In parallel, e-commerce platforms and health-focused marketplaces are enabling global access to niche and premium supplement brands. The intersection of menstrual health with broader wellness trends-such as gut health, mental wellness, and hormonal harmony-is driving cross-category product innovations that cater to a wider spectrum of consumer needs.

Investment interest in femtech and women-centric health ventures is fueling R&D and scaling capabilities for supplement companies, enabling faster product development and global expansion. Strategic partnerships between supplement brands and healthcare professionals are enhancing medical acceptance and consumer trust. With increasing integration into lifestyle wellness regimens, rising regulatory support for dietary supplements, and growing cultural normalization of menstruation, the PMS and menstrual health supplements market is expected to witness consistent, double-digit growth across both developed and emerging regions in the coming years.

SCOPE OF STUDY:

The report analyzes the Premenstrual Syndrome and Menstrual Health Supplements market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Combined Nutritional Supplements, Single Nutritional Supplements); Indication (Perimenopause Indication, PMS Indication); Form (Capsules / Tablets Form, Powder Form, Softgel Form, Other Forms); End-Use (Pharmacies / Drug Stores End-Use, Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Amway
  • Bayer AG
  • Bonafide Health, LLC
  • Eu Natural
  • FLO Living
  • Garden of Life (Nestle Health Science)
  • GNC Holdings, LLC
  • Health & Her
  • Himalaya Wellness Company
  • HUM Nutrition Inc.
  • i-Health, Inc. (DSM-Firmenich)
  • Kora Organics
  • MaryRuth Organics
  • MegaFood (FoodState Inc.)
  • Nature's Bounty Co.
  • New Chapter, Inc.
  • Nutrafol
  • Olly PBC
  • Pink Stork
  • Sakara Life

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Premenstrual Syndrome and Menstrual Health Supplements - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Awareness of Menstrual Wellness and Hormonal Health Drives Adoption of Targeted Supplements
    • Rising Female Workforce Participation Expands Addressable Market for Mood and Pain Relief Products
    • Shift Toward Natural and Botanical Formulations Throws the Spotlight on Herbal Menstrual Supplements
    • Expansion of Direct-to-Consumer Brands Strengthens Visibility of PMS and Menstrual Health Products
    • Technological Advancements in Nutraceutical Delivery Systems Enhance Bioavailability and Compliance
    • OEM Collaborations With Gynecologists and Wellness Experts Promote Clinical Validation of Supplements
    • Increasing Demand for Non-Pharmaceutical Alternatives Supports Preventive Supplement Adoption
    • Personalization Trends in Women's Health Propel Demand for Hormone-Specific Nutrient Combinations
    • Growth in E-Commerce and Subscription-Based Wellness Models Enhances Product Accessibility
    • Influencer and Social Media Advocacy Accelerates Market Education and Product Discovery
    • Regulatory Support for OTC Nutraceuticals in Menstrual Health Strengthens Global Product Expansion
    • Integration of Supplements Into Digital Health and Cycle-Tracking Apps Boosts Usage and Engagement
    • Demand for Clean-Label, Non-GMO, and Allergen-Free Formulations Supports Premium Segment Growth
    • Surge in Consumer Interest in Adaptogens and Ayurvedic Remedies Drives Alternative Medicine Offerings
    • Focus on Reducing Reliance on NSAIDs and Hormonal Drugs Fuels Preventive Supplement Trends
    • Increased Investment in R&D Around PMS Symptom Clusters Enhances Product Differentiation
    • Retail Pharmacy and Wellness Chain Expansion Improves Product Placement and Point-of-Care Sales
    • Cross-Selling With Multivitamins, Skin, and Mood Supplements Strengthens Portfolio Synergies
    • Rise in Mental Health Awareness Encourages Integration of PMS and Mood Support Formulations
    • Menstrual Equity and Inclusivity Movements Promote Diverse and Culturally Adapted Supplement Offerings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Premenstrual Syndrome and Menstrual Health Supplements Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Combined Nutritional Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Combined Nutritional Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Combined Nutritional Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Single Nutritional Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Single Nutritional Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Single Nutritional Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Online Distribution Channel End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Online Distribution Channel End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Online Distribution Channel End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Direct Distribution Channel End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Direct Distribution Channel End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Direct Distribution Channel End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharmacies / Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharmacies / Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pharmacies / Drug Stores End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Perimenopause Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Perimenopause Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Perimenopause Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for PMS Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for PMS Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for PMS Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Capsules / Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Capsules / Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Capsules / Tablets Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Powder Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Softgel Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Softgel Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Softgel Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • JAPAN
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Japan 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • CHINA
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: China 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: China 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: China 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: China 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • EUROPE
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • FRANCE
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 104: France Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: France 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: France 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: France 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: France 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • GERMANY
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Germany 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Germany 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Germany 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Germany 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Italy 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Italy 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Italy 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Italy 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 140: UK Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: UK 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: UK 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: UK 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: UK 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Spain 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Spain 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Spain 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Spain 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Russia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Russia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Russia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Russia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Australia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Australia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Australia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Australia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • INDIA
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 215: India Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: India 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: India 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: India 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 224: India Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: India 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: South Korea 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: South Korea 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: South Korea 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: South Korea 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Argentina 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Argentina 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Argentina 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Argentina 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Brazil 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Brazil 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Brazil 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: Brazil 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: Mexico 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: Mexico 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Mexico 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Mexico 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 316: Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 319: Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 322: Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 325: Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 328: Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 331: Iran 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 334: Iran 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 337: Iran 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 340: Iran 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 343: Israel 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 346: Israel 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 349: Israel 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 352: Israel 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 367: UAE 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 370: UAE 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 373: UAE 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 376: UAE 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030
  • AFRICA
    • Premenstrual Syndrome and Menstrual Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Combined Nutritional Supplements and Single Nutritional Supplements Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 391: Africa 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Product Type - Percentage Breakdown of Value Sales for Combined Nutritional Supplements and Single Nutritional Supplements for the Years 2014, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 394: Africa 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by End-Use - Percentage Breakdown of Value Sales for Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses and Pharmacies / Drug Stores End-Use for the Years 2014, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Perimenopause Indication and PMS Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 397: Africa 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Indication - Percentage Breakdown of Value Sales for Perimenopause Indication and PMS Indication for the Years 2014, 2025 & 2030
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Premenstrual Syndrome and Menstrual Health Supplements by Form - Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 400: Africa 16-Year Perspective for Premenstrual Syndrome and Menstrual Health Supplements by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Softgel Form and Other Forms for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제